Market Tracker

09/28 5:48pm ET

Nektar Therapeutics (NASDAQ:NKTR)

17.67
Delayed Data
As of 3:59pm ET
 +0.32 / +1.84%
Today’s Change
9.92
Today|||52-Week Range
19.98
+4.87%
Year-to-Date

Today’s Trading

Previous close17.35
Today’s open17.49
Day’s range17.40 - 18.08
Volume2,427,888
Average volume (3 months)1,107,915
Market cap$2.4B
Dividend yield--
Data as of 3:59pm ET, 09/28/2016

Growth & Valuation

Earnings growth (last year)-45.24%
Earnings growth (this year)-75.68%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+14.99%
P/E ratioNM
Price/Sales9.67
Price/Book365.11

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc+1.28+2.25%
EXASExact Sciences Corp-0.44-2.28%
ARIAARIAD Pharmaceutical...+0.19+1.36%
BLUEbluebird bio Inc-3.86-5.29%
Data as of 3:59pm ET, 09/28/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$230.8M
Annual profit (last year)-$81.2M
Net profit margin-35.17%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts